Randall Henner

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

Jennifer R. Diamond, Carlos Becerra, Donald Richards et al. · Breast Cancer Research and Treatment · 2020 · 149 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with paclitaxel (P) in patients (pts) with 1st- to 3rd-line metastatic HER2-negative breast cancer (BC).

Monica Mita, Carlos Becerra, Donald Richards et al. · Journal of Clinical Oncology · 2016 · 24 citations

Medicine, Oncology, Pharmacology +17

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)

Wells A. Messersmith, S. Cohen, Safi Shahda et al. · Annals of Oncology · 2016 · 20 citations · Full text

Medicine, Oncology, Pharmacology +11